Stanley-Laman Group’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
459,416
-71,218
-13% -$795K 0.43% 82
2026
Q1
$5.75M Buy
530,634
+31,719
+6% +$272K 0.71% 43
2025
Q4
$3.05M Buy
498,915
+72,633
+17% +$434K 0.39% 97
2025
Q3
$2.21M Buy
426,282
+85,104
+25% +$489K 0.31% 117
2025
Q2
$2.02M Sell
341,178
-10,603
-3% -$63.8K 0.3% 128
2025
Q1
$2.89M Buy
351,781
+31,671
+10% +$266K 0.44% 100
2024
Q4
$2.64M Buy
320,110
+3,288
+1% +$26.4K 0.37% 114
2024
Q3
$2.42M Buy
316,822
+18,278
+6% +$168K 0.34% 120
2024
Q2
$3.09M Buy
298,544
+70,229
+31% +$770K 0.44% 110
2024
Q1
$2.73M Buy
228,315
+61,003
+36% +$678K 0.38% 113
2023
Q4
$1.81M Buy
167,312
+25,919
+18% +$315K 0.28% 118
2023
Q3
$1.96M Buy
+141,393
New +$2.07M 0.33% 112

Other funds holding PTEN

Stanley-Laman Group's PTEN Position: Q2 2026 in Review

Stanley-Laman Group reduced its Patterson-UTI (PTEN) stake by 13% in Q2 2026, selling an estimated $795K and leaving 459,416 shares worth $4.22M. The position accounts for 0.43% of the portfolio, ranked #82.

Stanley-Laman Group first reported a position in PTEN in Q3 2023 and has held it in 12 quarters since. The position peaked at $5.75M in Q1 2026. 437 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Stanley-Laman Group held 459,416 shares of Patterson-UTI worth $4.22M as of Q2 2026.
  • Stanley-Laman Group sold 71,218 Patterson-UTI shares in Q2 2026, an estimated $795K.
  • Patterson-UTI made up 0.43% of Stanley-Laman Group's portfolio in Q2 2026, its #82 holding.
  • Stanley-Laman Group first reported a position in Patterson-UTI in Q3 2023 and has held it in 12 quarters since.
  • Stanley-Laman Group's Patterson-UTI position peaked at $5.75M in Q1 2026.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Stanley-Laman Group's 13F filing for Q2 2026, filed 5 Aug 2026.